- Home
- SQM vs NBIX Comparison
SQM vs NBIX Comparison
Compare SQM & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQM
- NBIX
- Stock Information
- Founded
- SQM 1968
- NBIX 1992
- Country
- SQM Chile
- NBIX United States
- Employees
- SQM N/A
- NBIX N/A
- Industry
- SQM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SQM Industrials
- NBIX Health Care
- Exchange
- SQM Nasdaq
- NBIX Nasdaq
- Market Cap
- SQM 11.3B
- NBIX 11.0B
- IPO Year
- SQM 1993
- NBIX 1996
- Fundamental
- Price
- SQM $35.82
- NBIX $106.73
- Analyst Decision
- SQM Hold
- NBIX Strong Buy
- Analyst Count
- SQM 8
- NBIX 20
- Target Price
- SQM $45.56
- NBIX $162.30
- AVG Volume (30 Days)
- SQM 1.3M
- NBIX 1.8M
- Earning Date
- SQM 05-21-2025
- NBIX 05-05-2025
- Dividend Yield
- SQM 0.60%
- NBIX N/A
- EPS Growth
- SQM N/A
- NBIX 33.20
- EPS
- SQM N/A
- NBIX 3.29
- Revenue
- SQM $4,528,761,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- SQM N/A
- NBIX $15.36
- Revenue Next Year
- SQM N/A
- NBIX $16.34
- P/E Ratio
- SQM N/A
- NBIX $32.44
- Revenue Growth
- SQM N/A
- NBIX 24.81
- 52 Week Low
- SQM $31.27
- NBIX $84.23
- 52 Week High
- SQM $50.73
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- SQM 45.33
- NBIX 54.68
- Support Level
- SQM $33.94
- NBIX $101.15
- Resistance Level
- SQM $36.78
- NBIX $106.20
- Average True Range (ATR)
- SQM 2.01
- NBIX 4.74
- MACD
- SQM 0.18
- NBIX 1.87
- Stochastic Oscillator
- SQM 73.15
- NBIX 96.77
About SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM is developing a hard rock lithium project in Australia and expanding its lithium refining assets in China.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.